Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2386–2400 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5477 SMARCAD1 Gene Adermatoglyphia Genetic Test This test identifies pathogenic or likely pathogenic variants in the SMARCAD1 gene associated with autosomal dominant adermatoglyphia.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMARCAD1 gene", "Single nucleotide variants", "Small insertions", "Small deletions"] Parameters [] Preparation ["A comprehensive clinical history must be submitted.", "A mandatory pre-test genetic counselling session is required.", "No fasting is required.", "Obtain clearance from treating physician if on anticoagulant therapy."] Indications ["Suspected diagnosis of autosomal dominant adermatoglyphia", "Family history of adermatoglyphia", "Need for definitive genetic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 81335-5 ICD-10: Q84.8 Clinical summary This test identifies pathogenic or likely pathogenic variants in the SMARCAD1 gene associated with autosomal dominant adermatoglyphia.
TEST-3209 SMARCAL1 Gene Schimke Immuno‑Osseous Dysplasia Genetic Test (NGS) This test identifies pathogenic variants in the SMARCAL1 gene, confirming a diagnosis of Schimke immuno-osseous dysplasia.	Blood, FTA Card, or Extracted DNA	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMARCAL1 gene pathogenic variants", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Suspected Schimke immuno-osseous dysplasia", "Family history of SIOD", "Genetic counseling for related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the SMARCAL1 gene, confirming a diagnosis of Schimke immuno-osseous dysplasia.
TEST-4811 SMARCB1 Gene Genetic Test for Intellectual Disability (Autosomal Dominant Type 15) This genetic test evaluates the SMARCB1 gene for pathogenic variants associated with intellectual disability type 15 and cancer predisposition.	Peripheral Blood, DNA, or FTA Card Spot (Whole Blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMARCB1 gene pathogenic variants (SNVs, indels, copy number variants)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Diagnosis of autosomal dominant intellectual disability type 15", "Assessment of cancer predisposition syndromes", "Recurrence risk assessment in families"] Measurement technique Confirm with laboratory Codes LOINC: 87613-9 ICD-10: Q87.8 Clinical summary This genetic test evaluates the SMARCB1 gene for pathogenic variants associated with intellectual disability type 15 and cancer predisposition.
TEST-2948 SMARCE1 Gene Genetic Test for Coffin-Siris Syndrome This diagnostic test evaluates the SMARCE1 gene for pathogenic variants associated with Coffin-Siris syndrome and meningioma predisposition.	Peripheral whole blood (FTA card or EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMARCE1 gene sequence", "Copy Number Variations (CNVs) in SMARCE1"] Parameters [] Preparation ["Do not discontinue prescribed medications without consulting your physician", "Inform the phlebotomist if on anticoagulants"] Indications ["Clinical suspicion of Coffin-Siris syndrome", "Family history of Coffin-Siris syndrome", "Evaluation for hereditary predisposition to clear cell meningiomas"] Measurement technique Confirm with laboratory Codes LOINC: 92709-6 ICD-10: Q87.1, Q85.8 Clinical summary This diagnostic test evaluates the SMARCE1 gene for pathogenic variants associated with Coffin-Siris syndrome and meningioma predisposition.
TEST-5258 SMC1A Gene Cornelia de Lange Syndrome Type 2 Genetic Test This test detects pathogenic variants in the SMC1A gene, confirming a diagnosis of Cornelia de Lange syndrome type 2.	Peripheral blood, dried blood spot, or extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMC1A gene"] Parameters [] Preparation ["No special fasting or preparation is required for blood collection.", "For dried blood spots, a trained phlebotomist ensures proper sample quality."] Indications ["Suspected Cornelia de Lange syndrome type 2", "Confirmation of diagnosis", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94297-1 ICD-10: Q87.1 Clinical summary This test detects pathogenic variants in the SMC1A gene, confirming a diagnosis of Cornelia de Lange syndrome type 2.
TEST-5569 SMPX Gene (Deafness, X-Linked Type 4) Genetic Test This test detects pathogenic variants in the SMPX gene associated with X-linked type 4 non-syndromic hearing loss.	Whole blood, Extracted DNA, or FTA Card	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMPX gene coding region", "SMPX gene splice sites"] Parameters [] Preparation [] Indications ["Diagnosis of X-linked type 4 deafness", "Carrier screening for at-risk family members", "Assessment for cochlear implant candidacy"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.3 Clinical summary This test detects pathogenic variants in the SMPX gene associated with X-linked type 4 non-syndromic hearing loss.
TEST-5081 SMS Gene Snyder-Robinson Syndrome Genetic Test This test evaluates the SMS gene for pathogenic variants associated with Snyder-Robinson syndrome.	Whole Blood (EDTA) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMS gene coding region", "SMS gene splice sites", "Pathogenic variants in the SMS gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory.", "Signed informed consent form is required."] Indications ["Males with unexplained intellectual disability, hypotonia, seizures, and dysmorphic features.", "Individuals with a family history suggestive of X-linked intellectual disability.", "Carrier females seeking reproductive planning."] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E70.8, F70 Clinical summary This test evaluates the SMS gene for pathogenic variants associated with Snyder-Robinson syndrome.
TEST-5854 SNAI2 Gene (Waardenburg Syndrome Type 2D) Next-Generation Sequencing (Genetic Test This genetic test analyzes the SNAI2 gene to detect variants associated with Waardenburg syndrome type 2D.	Peripheral whole blood (3–5 mL in EDTA lavender-top tube) or saliva (Oragene DNA collection kit)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SNAI2 gene variants", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [{"name": "Method Precision", "reference_range": "99.9% base-level accuracy"}] Preparation ["No dietary restrictions", "No supplemental modifications", "No medication adjustments required"] Indications ["Suspected Waardenburg syndrome type 2D", "Family history of Waardenburg syndrome", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.0 Clinical summary This genetic test analyzes the SNAI2 gene to detect variants associated with Waardenburg syndrome type 2D.
TEST-2982 SNAP29 Gene CEDNIK Syndrome Genetic Test This test evaluates the SNAP29 gene for pathogenic variants associated with CEDNIK syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SNAP29 gene", "Copy number changes in the SNAP29 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any anticoagulant therapy or bleeding disorders"] Indications ["Individuals with clinical features suggestive of CEDNIK syndrome", "Family members of individuals diagnosed with CEDNIK syndrome for carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 91719-8 ICD-10: Q87.8 Clinical summary This test evaluates the SNAP29 gene for pathogenic variants associated with CEDNIK syndrome.
TEST-5409 SNCA Gene (PARK1) Parkinson’s Disease Genetic Test This test evaluates the SNCA gene for pathogenic variants associated with autosomal dominant Parkinson's disease.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SNCA gene variants", "Alpha-synuclein gene mutations"] Parameters [] Preparation [] Indications ["Individuals with a strong family history of early-onset Parkinson’s disease", "Differential diagnosis of Parkinsonism", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94266-0 ICD-10: Z13.83 Clinical summary This test evaluates the SNCA gene for pathogenic variants associated with autosomal dominant Parkinson's disease.
TEST-4199 SNCA Gene Dementia & Lewy Body Genetic Test This test evaluates the SNCA gene for pathogenic variants associated with Lewy body dementia and Parkinson's disease dementia.	Whole blood, extracted DNA, or dry blood spot (FTA card)	3–4 weeks (21–28 days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SNCA gene pathogenic variants", "α-synuclein aggregation risk"] Parameters [] Preparation [] Indications ["Strong family history of Lewy body dementia or Parkinson's disease dementia", "Patients presenting with symptoms suggestive of synucleinopathies"] Measurement technique Confirm with laboratory Codes LOINC: 73518-2 ICD-10: G31.84 Clinical summary This test evaluates the SNCA gene for pathogenic variants associated with Lewy body dementia and Parkinson's disease dementia.
TEST-5611 SNRPN Gene Prader-Willi Syndrome Genetic Test This test analyzes the SNRPN gene to detect genetic changes associated with Prader-Willi syndrome.	Whole Blood (Peripheral) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SNRPN gene variants", "Deletions", "Duplications", "Methylation defects", "Uniparental disomy (UPD)"] Parameters [] Preparation ["A mandatory genetic counseling session is required prior to testing."] Indications ["Clinical suspicion of Prader-Willi syndrome", "Documented family history of Prader-Willi syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.1, Z13.79, Z15.09 Clinical summary This test analyzes the SNRPN gene to detect genetic changes associated with Prader-Willi syndrome.
TEST-4187 SNTA1 Gene LQTS Type 12 Genetic Test This test identifies mutations in the SNTA1 gene associated with Long QT Syndrome type 12.	Blood, Saliva, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SNTA1 gene mutations", "Cardiac ion channelopathy risk"] Parameters [] Preparation ["No fasting required"] Indications ["Family history of LQTS", "Unexplained syncope", "Prolonged QT interval on ECG"] Measurement technique Confirm with laboratory Codes LOINC: 94759-3 ICD-10: I45.81 Clinical summary This test identifies mutations in the SNTA1 gene associated with Long QT Syndrome type 12.
TEST-4703 SNX10 Gene Osteopetrosis of Infancy, Malignant Genetic Test This test detects pathogenic variants in the SNX10 gene associated with malignant infantile osteopetrosis.	Whole blood (EDTA), FTA card, or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SNX10 gene", "Coding region and flanking intronic boundaries of SNX10"] Parameters [] Preparation ["No fasting required", "No dietary changes required", "No medication adjustments required"] Indications ["Infants presenting with features of malignant osteopetrosis", "Familial screening for SNX10-related osteopetrosis"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q78.2 Clinical summary This test detects pathogenic variants in the SNX10 gene associated with malignant infantile osteopetrosis.
TEST-4024 SNX14-Related Cerebellar Ataxia Genetic Test This test identifies pathogenic variants in the SNX14 gene associated with autosomal recessive spinocerebellar ataxia type 20 (SCAR20).	Peripheral Whole Blood (3–5 mL in EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SNX14 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["Attend a genetic counseling session", "No prolonged fasting required"] Indications ["Suspected autosomal recessive spinocerebellar ataxia type 20 (SCAR20)", "Family history of cerebellar ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 81248-8 ICD-10: G11.9, G11.1 Clinical summary This test identifies pathogenic variants in the SNX14 gene associated with autosomal recessive spinocerebellar ataxia type 20 (SCAR20).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories